A carregar...
Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
Diabetic kidney disease remains the leading cause of end‐stage kidney disease and a major risk factor for cardiovascular disease. Large cardiovascular outcome trials and dedicated kidney trials have shown that sodium‐glucose cotransporter (SGLT)2 inhibitors reduce cardiovascular morbidity and mortal...
Na minha lista:
| Publicado no: | Nephrology (Carlton) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons Australia, Ltd
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8026736/ https://ncbi.nlm.nih.gov/pubmed/33283420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nep.13839 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|